Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
- PMID: 32408338
- PMCID: PMC7394720
- DOI: 10.1038/s41586-020-2342-5
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus with high nucleotide identity to SARS-CoV and to SARS-related coronaviruses that have been detected in horseshoe bats, has spread across the world and had a global effect on healthcare systems and economies1,2. A suitable small animal model is needed to support the development of vaccines and therapies. Here we report the pathogenesis and transmissibility of SARS-CoV-2 in golden (Syrian) hamsters (Mesocricetus auratus). Immunohistochemistry assay demonstrated the presence of viral antigens in nasal mucosa, bronchial epithelial cells and areas of lung consolidation on days 2 and 5 after inoculation with SARS-CoV-2, followed by rapid viral clearance and pneumocyte hyperplasia at 7 days after inoculation. We also found viral antigens in epithelial cells of the duodenum, and detected viral RNA in faeces. Notably, SARS-CoV-2 was transmitted efficiently from inoculated hamsters to naive hamsters by direct contact and via aerosols. Transmission via fomites in soiled cages was not as efficient. Although viral RNA was continuously detected in the nasal washes of inoculated hamsters for 14 days, the communicable period was short and correlated with the detection of infectious virus but not viral RNA. Inoculated and naturally infected hamsters showed apparent weight loss on days 6-7 post-inoculation or post-contact; all hamsters returned to their original weight within 14 days and developed neutralizing antibodies. Our results suggest that features associated with SARS-CoV-2 infection in golden hamsters resemble those found in humans with mild SARS-CoV-2 infections.
Conflict of interest statement
COMPETING INTERESTS
The authors declare no competing interest.
Figures
![Extended Data Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7394720/bin/nihms-1592410-f0004.gif)
![Extended Data Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7394720/bin/nihms-1592410-f0005.gif)
![Extended Data Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7394720/bin/nihms-1592410-f0006.gif)
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7394720/bin/nihms-1592410-f0001.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7394720/bin/nihms-1592410-f0002.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7394720/bin/nihms-1592410-f0003.gif)
Similar articles
-
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.Nature. 2020 Jul;583(7818):830-833. doi: 10.1038/s41586-020-2312-y. Epub 2020 May 7. Nature. 2020. PMID: 32380511
-
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595. doi: 10.1073/pnas.2009799117. Epub 2020 Jun 22. Proc Natl Acad Sci U S A. 2020. PMID: 32571934 Free PMC article.
-
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.Science. 2020 Aug 14;369(6505):812-817. doi: 10.1126/science.abc4776. Epub 2020 May 20. Science. 2020. PMID: 32434946 Free PMC article.
-
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.
-
Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2.Comp Med. 2021 Oct 1;71(5):398-410. doi: 10.30802/AALAS-CM-21-000036. Epub 2021 Sep 29. Comp Med. 2021. PMID: 34588095 Free PMC article. Review.
Cited by
-
Decisive reversal of lethal coronavirus disease 2019 in senescent hamster by synchronic antiviral and immunoregulatory intervention.MedComm (2020). 2024 Jul 19;5(8):e642. doi: 10.1002/mco2.642. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39036342 Free PMC article.
-
The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.Emerg Microbes Infect. 2024 Dec;13(1):2353302. doi: 10.1080/22221751.2024.2353302. Epub 2024 May 26. Emerg Microbes Infect. 2024. PMID: 38753462 Free PMC article.
-
Co-Mutations and Possible Variation Tendency of the Spike RBD and Membrane Protein in SARS-CoV-2 by Machine Learning.Int J Mol Sci. 2024 Apr 25;25(9):4662. doi: 10.3390/ijms25094662. Int J Mol Sci. 2024. PMID: 38731879 Free PMC article.
-
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera.bioRxiv [Preprint]. 2024 Apr 6:2024.04.05.588359. doi: 10.1101/2024.04.05.588359. bioRxiv. 2024. PMID: 38712124 Free PMC article. Preprint.
-
Analysis the molecular similarity of least common amino acid sites in ACE2 receptor to predict the potential susceptible species for SARS-CoV-2.PLoS One. 2024 May 2;19(5):e0293441. doi: 10.1371/journal.pone.0293441. eCollection 2024. PLoS One. 2024. PMID: 38696505 Free PMC article.
References
-
- WHO. Coronavirus disease (COVID-2019) situation reports, <https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...> (2020).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous